These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 16426913)

  • 21. Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.
    Lindgren D; Liedberg F; Andersson A; Chebil G; Gudjonsson S; Borg A; Månsson W; Fioretos T; Höglund M
    Oncogene; 2006 Apr; 25(18):2685-96. PubMed ID: 16532037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
    Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
    Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer.
    Hirao S; Hirao T; Marsit CJ; Hirao Y; Schned A; Devi-Ashok T; Nelson HH; Andrew A; Karagas MR; Kelsey KT
    Cancer; 2005 Nov; 104(9):1918-23. PubMed ID: 16149093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells.
    Simon R; Eltze E; Schäfer KL; Bürger H; Semjonow A; Hertle L; Dockhorn-Dworniczak B; Terpe HJ; Böcker W
    Cancer Res; 2001 Jan; 61(1):355-62. PubMed ID: 11196186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.
    Kobayashi M; Kawashima A; Mai M; Ooi A
    Am J Pathol; 1996 Nov; 149(5):1575-84. PubMed ID: 8909247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract.
    Takahashi T; Habuchi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Yoshida O
    Cancer Res; 1998 Dec; 58(24):5835-41. PubMed ID: 9865743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular clonal analysis of recurrent bladder cancer.
    Junker K; Wolf M; Schubert J
    Oncol Rep; 2005 Aug; 14(2):319-23. PubMed ID: 16012709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of genetic events in 17p13 and 9p21 regions supports predominant monoclonal origin of multifocal and recurrent bladder cancer.
    Trkova M; Babjuk M; Duskova J; Benesova-Minarikova L; Soukup V; Mares J; Minarik M; Sedlacek Z
    Cancer Lett; 2006 Oct; 242(1):68-76. PubMed ID: 16343743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.
    Adams J; Williams SV; Aveyard JS; Knowles MA
    Cancer Res; 2005 Jan; 65(1):66-75. PubMed ID: 15665280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Urothelial neoplasms in individuals younger than 20 years show very few genetic alterations and have a favourable clinical outcome].
    Giedl J; Wild PJ; Stoehr R; Junker K; Boehm S; van Oers JM; Zwarthoff EC; Blaszyk H; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Hartmann A
    Verh Dtsch Ges Pathol; 2006; 90():253-63. PubMed ID: 17867604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
    Asali MG; Kaneti J; Manor E
    Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
    Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
    Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The diagnostic value of microsatellite LOH analysis and the prognostic relevance of angiogenic gene expression in urinary bladder cancer].
    Szarvas T
    Magy Onkol; 2009 Dec; 53(4):385-9. PubMed ID: 20071311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High frequency loss of heterozygosity in the region of the DBH locus in bladder cancer.
    Yang X; Shen P; Yao K; Mi Z; Liu S; Zhang H; Wang D; Liu C; Liu H
    Chin Med J (Engl); 2000 Feb; 113(2):117-9. PubMed ID: 11775532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.
    Bartoletti R; Cai T; Nesi G; Roberta Girardi L; Baroni G; Dal Canto M
    J Surg Res; 2007 Dec; 143(2):422-7. PubMed ID: 17612565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger.
    Wild PJ; Giedl J; Stoehr R; Junker K; Boehm S; van Oers JM; Zwarthoff EC; Blaszyk H; Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI; Hartmann A
    J Pathol; 2007 Jan; 211(1):18-25. PubMed ID: 17072825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
    Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lasermicrodissection--an important prerequisite for the molecular-genetic analysis of bladder cancer.
    Stoehr R; Wild P; Hartmann A
    Pathol Res Pract; 2003; 199(6):355-62. PubMed ID: 12924435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.